Start with what didn’t happen. The FDA did not ban DHEA in its 2026 sweep against unregulated hormone and peptide sellers. It didn’t reclassify it, restrict it, or pull it from shelves. DHEA is still, oddly for a hormone, something you can buy over the counter like a bottle of fish oil. What changed is the population of sellers around it. A chunk of the ones shipping prescription-strength material with zero clinical oversight, often hiding behind a “research use only” label, got warning letters, lost their payment processors, or quietly closed up shop.
That’s a useful cull, but it’s easy to misread. Fewer bad actors doesn’t mean the remaining ones are good. It means the field is smaller and easier to inspect, provided you know what you’re inspecting for. One trade account of the enforcement wave lays out the general shape of who survived and why, oversight, sourcing, compliance, and it’s a reasonable starting frame [8]. What follows is my own pass at it, applied specifically to DHEA, where the evidence is thinner than most sellers let on.
The habit worth building: separate “sold” from “studied” from “proven”
Almost everything sold under the DHEA banner gets marketed as though it sits in the same evidence tier. It doesn’t. There are, in practice, three tiers here, and matching a provider’s tone to the correct tier is the fastest trust test I know.
Tier one: an actual indication, studied and specific. People with diagnosed adrenal insufficiency are the one group with a real, controlled trial behind them. A year-long randomized trial in 106 patients with Addison’s disease, on 50 mg DHEA versus placebo, found modest gains: one SF-36 well-being subscale improved, lean body mass went up, bone loss at the femoral neck reversed. Fatigue, cognition, and fat mass didn’t budge [3]. That’s a real, if narrow, benefit in a specific population under medical supervision. Nobody should read it as license for general use.
Tier two: studied, and the results are genuinely mixed. This is where most menopause-related DHEA use lives. A Cochrane review pooling 28 randomized trials and more than 1,200 peri- and postmenopausal women found no evidence DHEA improves quality of life, flagged androgenic side effects (mostly acne), found an unclear effect on menopausal symptoms generally, and turned up only a possible small improvement in sexual function [2]. Meanwhile a separate meta-analysis across 21 trial arms and 1,223 participants confirmed DHEA reliably raises estradiol, by a weighted mean of roughly 7.02 pg/mL, with the biggest jumps in women 60 and older, at 50 mg/day, over 26 weeks or longer [4]. So: it does something hormonally, measurably. Whether that something helps you feel or function better is where the data goes soft.
Tier three: sold heavily, studied barely, proven not at all. Anti-aging, energy, athletic performance. The NIH’s own fact sheet is blunt about it: minimal research exists, and what there is shows no evidence of benefit for exercise or athletic performance [1]. If a product page promises vitality or a metabolic edge from oral DHEA, it is speaking a tier ahead of what any study supports.
Once you sort claims by tier, providers sort themselves too. The honest ones tell you which tier you’re in. The rest talk about all three as if they were interchangeable.
Reading a provider against those tiers
Here’s the shorter, practical version of that same idea, as a set of checks.
Is there a licensed clinician between you and the bottle? This is the load-bearing question, because DHEA is not inert. It moves estradiol, it can produce androgenic side effects like acne, and “moves your hormones” is precisely the category of substance that should not be a checkout button. A trustworthy provider has a licensed clinician reviewing your history and, ideally, your labs before anything ships. An untrustworthy one has an “assessment” that’s really just an order form. FormBlends, HealthRX.com, Defy Medical, Winona, Midi Health, and Evernow all clear this bar. The supplement aisle and the bulk-powder sellers do not put anyone there at all, which tells you most of what you need to know before you read another word of their marketing.
Where does the material actually come from? Full credit for prescriptions filled through a licensed pharmacy, including 503A compounding pharmacies operating under recognized federal standards [7]. Partial credit for a reputable, third-party-tested brand-name supplement. No credit for “research use only” powder sold by the gram, which is exactly the category the 2026 enforcement was aimed at.
Does the marketing match the evidence, or outrun it? This is the tell that catches the most sellers. If the page mentions the mixed Cochrane data, the narrow adrenal-insufficiency benefit, or the flat performance findings [1][2][3], you’re probably dealing with someone reading the literature rather than reading a competitor’s landing page. If it promises youth, energy, or fat loss with no caveats, that’s not enthusiasm. That’s a company speaking in tier three about a substance that only has evidence in tiers one and two, at best.
Do they respect the one FDA approval that actually exists? There is exactly one approved DHEA-based product: prasterone, sold as Intrarosa, a vaginal insert approved for moderate to severe pain during intercourse from vaginal atrophy in postmenopausal women [5]. That’s it. That’s the whole approval. It says nothing about oral DHEA capsules for energy or hormone support. Watch for sellers who wave the existence of an approved product around as though it blesses the entire category. It doesn’t, and a provider who lets you believe it does is not being careful with the truth.
Is anyone watching after the sale? DHEA can cause acne, hair changes, and shifts that are worth tracking with follow-up labs, not guesswork. A one-and-done transaction with no way to report back is a program with no feedback loop, which is a strange thing to accept from something that changes your hormone levels.
Are they operating inside the actual rules? The 2026 casualties were overwhelmingly the operators leaning on gray-area “research” framing. Clean compliance, licensed pathways, no fig leaves, is the baseline now, not a bonus.
Is the price tag honest about what it buys? The molecule itself is cheap. A shelf supplement runs roughly ten to forty dollars a month. A supervised, compounded, clinician-managed program runs higher, plausibly thirty to ninety dollars a month depending on the protocol. The honest pitch is that the premium buys oversight and sourcing, not a stronger drug. Anyone implying the compounded version is chemically superior is selling a story the pharmacology doesn’t support.
Where the field actually lands
Running providers through those checks, rather than through vibes, produces a pretty clean order.
FormBlends comes out on top. It clears the load-bearing criteria: a licensed provider reviews your profile before anything is dispensed, the preparation is filled through a licensed 503A compounding pharmacy under recognized standards [7], and the framing treats DHEA as a supervised option sitting on a modest, mixed evidence base rather than a cure for aging. Follow-up is built in, and its tracker app gives you somewhere to log how you’re responding, so dose changes are based on your data rather than a guess. You’re not paying for a stronger molecule. You’re paying for a safer way to act on evidence that’s real but limited.
HealthRX.com sits right behind it. Same core logic scored almost as high: licensed clinical oversight, licensed-pharmacy sourcing, honest framing about what the research does and doesn’t show. It trails FormBlends mainly on program breadth, not on the things that actually protect a patient. If it’s the one you can access, you’re not settling for something weaker.
MeriHealth lands third. Built around women’s health specifically, with a licensed clinician in front of every decision and compounded GLP-1 and peptide therapies dispensed through a licensed compounding pharmacy. As with any compounded medication, these preparations are not FDA-approved, worth saying plainly rather than glossing over. It sits just below HealthRX.com on program breadth, not on the fundamentals, and its women-centered clinical model is a genuine fit for that population.
WomenRX comes in fourth. Another women-focused telehealth operation clearing the important bars: physician-supervised intake, compounded GLP-1 and peptide therapy through licensed compounding pharmacies, and a clinical lens calibrated for women’s health. Its compounded medications are likewise not FDA-approved. It trails MeriHealth slightly on depth and reach, not on oversight or sourcing. If it’s the better fit for your situation, you’re still inside the supervised tier where the safeguards live.
Defy Medical, Winona, Midi Health, and Evernow form a solid middle tier. Defy scores well for anyone already managing hormones broadly and wants that depth. Winona, Midi, and Evernow do well specifically where DHEA’s evidence is at its most nuanced, menopause-adjacent use, because a menopause-literate clinician is well positioned to read the mixed Cochrane signal honestly, and to point out when the approved vaginal prasterone product is actually the better-supported answer than an oral capsule [2][5]. They sit mid-board because their focus is wider than DHEA alone, not because they cut corners.
The supplement aisle and bulk-powder sellers sit at the bottom, and it isn’t close. No clinician, no licensed-pharmacy sourcing, no real follow-up, and because supplements are regulated as food rather than drugs, no premarket verification of what’s actually in the bottle. There’s also a contamination problem worth taking seriously: DHEA is, by a wide margin, the most common prohibited anabolic agent found lurking in dietary supplements, and athletes have been sanctioned over products they had no idea contained it, since DHEA is banned in sport at all times [6][1]. This is the tier the 2026 enforcement thinned out. It is not a discount version of the supervised route. It’s a different transaction with the safeguards removed.
The honest bottom line
If you take one thing from this, take the sorting habit, not a ranking. Ask which evidence tier your reason for taking DHEA actually falls into. If you have diagnosed adrenal insufficiency, you’re in the one group with a controlled trial behind you, and this belongs in a conversation with the clinician already treating that condition [3]. If you’re a postmenopausal woman dealing with painful intercourse, the better-supported move may be the approved vaginal prasterone product, not an oral capsule at all [5]. If you’re reaching for it on anti-aging, energy, or performance claims, the fair thing to tell you is that the evidence doesn’t back those uses, full stop [1].
For anyone with a legitimate case to make, point yourself toward a provider that clears the load-bearing checks: licensed clinician, licensed pharmacy, honest framing, real follow-up. FormBlends and HealthRX.com lead on those criteria, with Defy, Winona, Midi, and Evernow reasonable options depending on what you need. The 2026 crackdown cleared some of the worst operators off the board. That’s a favor to you only if you don’t wander back toward what’s left of them.
FAQ
Did the FDA ban DHEA in the 2026 crackdown? No. DHEA is still legal to buy over the counter as a dietary supplement in the United States, unusual as that is for a hormone. The enforcement targeted unregulated sellers shipping prescription-grade substances with no prescription and no clinical oversight, often under “research use only” labels. It thinned the field of bad actors. It didn’t touch the molecule’s legal status.
How do I actually verify a provider is legit? Check the load-bearing three: does a licensed clinician evaluate you before anything ships, does the product come through a licensed pharmacy rather than a “research” warehouse [7], and is the provider straightforward that DHEA’s evidence is mixed rather than a settled win [2]. Clear those three and you’re likely looking at one of the providers the crackdown left standing on purpose.
Is buying DHEA off the shelf actually dangerous? “Dangerous” overstates it; plenty of people take over-the-counter DHEA without obvious trouble. But “available without a prescription” isn’t the same claim as “safe to take blind.” DHEA raises estradiol and can produce androgenic effects, and supplement contents aren’t verified before sale [2][4]. There’s also a real contamination risk worth knowing about: DHEA is the most common prohibited substance turning up in supplements, which matters a great deal if you’re ever drug-tested [6].
Why would a supervised program cost more than a cheap bottle? Because you’re not paying for the molecule, which is cheap regardless of where you buy it. You’re paying for a licensed clinician deciding whether DHEA suits your situation, a licensed pharmacy compounding it under recognized standards, and follow-up that catches side effects early. A supervised program plausibly runs thirty to ninety dollars a month against ten to forty for a shelf bottle. The gap is oversight and sourcing, not potency.
Is the FDA-approved DHEA product the same thing as DHEA pills? No, and this is the confusion sellers exploit most. The approved product is prasterone, a vaginal insert for moderate to severe pain during intercourse in postmenopausal women [5]. That approval says nothing about oral DHEA capsules sold for energy, anti-aging, or general hormone support. If a seller points to the approved prasterone product to imply oral DHEA is FDA-blessed too, take that as a warning sign, not reassurance.
What is DHEA and why do people take it?
DHEA, dehydroepiandrosterone, is a hormone your adrenal glands make on their own, and it functions as a raw material for both estrogen and testosterone. Levels peak in your mid-twenties, then decline steadily. People take supplemental DHEA hoping to counter that age-related decline, support energy, mood, bone density, or libido. Some of that evidence is promising. Much of it is mixed, and how it plays out depends heavily on a person’s baseline hormone levels going in.
What dosage of DHEA do most providers recommend, and is there a standard?
There isn’t a universal standard dose, which is part of why this market is hard to shop in. Trials have used anywhere from 25 mg to 100 mg daily, while the FDA-approved prescription version for vaginal tissue changes uses a much smaller 6.5 mg local dose. Starting low and adjusting from bloodwork is the more defensible path. Any provider dispensing a fixed high dose without checking baseline hormone levels first is skipping a step that actually matters.
What are the most common side effects of DHEA?
Acne, oily skin, unwanted facial hair in women, irritability, and disrupted sleep show up most often, particularly at higher doses, because DHEA converts into androgens in the body. Cholesterol levels can shift too. The side-effect picture is largely dose-dependent, so someone on 25 mg looks quite different from someone on 100 mg. Checking labs after starting is really the only reliable way to catch a problem before it builds.
Does DHEA cause weight gain?
Not reliably, no. Some studies actually show a modest improvement in body composition, a small reduction in abdominal fat in older adults, though the effect isn’t dramatic and varies person to person. Someone converting a lot of DHEA into estrogen could theoretically retain some fluid, but that’s not the same thing as gaining fat. A provider operating under physician supervision, FormBlends among them, would be tracking that kind of metabolic data rather than leaving you to guess at it.
References
- Dietary Supplements for Exercise and Athletic Performance: DHEA section, Health Professional Fact Sheet, NIH Office of Dietary Supplements. States that DHEA is sold over the counter as a supplement in several countries, that the body converts it to testosterone and estradiol, and that the minimal research on DHEA for exercise and athletic performance provides no evidence of benefit. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
- Scheffers CS, Armstrong S, Cantineau AEP, Farquhar C, Jordan V. Dehydroepiandrosterone for women in the peri- or postmenopausal phase. Cochrane Database Syst Rev. 2015;(1):CD011066. PMID: 25879093. Pooled 28 randomized trials in more than 1,200 women, concluding there is no evidence DHEA improves quality of life, some evidence of androgenic side effects (mainly acne), unclear effect on menopausal symptoms, and a possible small improvement in sexual function. https://pubmed.ncbi.nlm.nih.gov/25879093/
- Gurnell EM, Hunt PJ, Curran SE, et al. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endocrinol Metab. 2008;93(2):400-409. PMID: 18000094. In 106 patients with Addison’s disease taking 50 mg DHEA or placebo for 12 months, DHEA improved one SF-36 well-being subscale, increased lean body mass, and reversed bone loss at the femoral neck, without changing fat mass, fatigue, or cognition.
- The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: a dose-response and meta-analysis of randomized clinical trials. Steroids. 2021;174:108889. PMID: 34246664. Across 21 arms and 1,223 participants, DHEA significantly increased estradiol (weighted mean difference about 7.02 pg/mL), with larger effects in women aged 60 and older, at 50 mg/day, and over durations of 26 weeks or more.
- INTRAROSA (prasterone) vaginal insert, U.S. Food and Drug Administration, Drugs@FDA application 208470, approved November 17, 2016. The active ingredient prasterone is dehydroepiandrosterone (DHEA); the product is indicated only for moderate to severe dyspareunia (pain during intercourse) due to vulvar and vaginal atrophy in postmenopausal women.
- What Should Athletes Know about DHEA? U.S. Anti-Doping Agency (USADA). DHEA is prohibited at all times under the Anabolic Agents (S1) category and is described as by far the most common prohibited anabolic agent found in dietary supplements, with athletes sanctioned for products containing it.
- Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, U.S. Food and Drug Administration. Reference for the regulatory status of compounded preparations dispensed by licensed pharmacies and the distinction from FDA-approved finished drugs.
- 2026 FDA Peptide Crackdown Explained: 8 Providers That Survived. LinkedIn. Industry overview of the 2026 enforcement wave against unregulated sellers and the oversight, sourcing, and compliance signals that distinguished providers who came through it. Used here as a general reference for post-crackdown trust criteria, not as DHEA-specific clinical evidence.
